As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

The combination of chemotherapy and radioembolization appeared safe and effective in patients with well-differentiated, liver-dominant, grade 3 NETs.

Or they might also give a chemotherapy drug to the liver at the same ... you have an increase in pain and get a temperature when you are at home. Treatment for neuroendocrine cancer can be difficult ...

Common types of neuroendocrine pancreatic cancer ... There are several chemotherapy regimens for treating pancreatic cancer. Most people receive two or more of the following chemo drugs ...

and the potential treatment of SCLC and neuroendocrine tumors. These forward-looking statements may contain words such as “aim,” “anticipate,” “believe,” “could,” “estimate ...

Evidence for chemotherapy ... for breast cancer or androgen ablation for prostate cancer. The effects of chemotherapy-associated cardiovascular toxicity and alterations in neuroendocrine function ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Median overall survival did not differ significantly between the two arms, but median progression-free survival was significantly longer in the treatment ... and neuroendocrine tumors as well ...

Pancreatic enzyme replacement therapy (Pert) provides the enzymes people affected by pancreatic cancer need to absorb ...

total of 218 consecutive patients with pathologically confirmed neuroendocrine ... resection after chemotherapy is still alive after 15.2 months without evidence of tumor recurrence.

Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...